157 related articles for article (PubMed ID: 34329741)
21. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression.
de Assis S; Warri A; Benitez C; Helferich W; Hilakivi-Clarke L
Cancer Prev Res (Phila); 2011 Sep; 4(9):1436-48. PubMed ID: 21680703
[TBL] [Abstract][Full Text] [Related]
23. BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.
van de Ven M; Liu X; van der Burg E; Klarenbeek S; Alexi X; Zwart W; Dijcks F; Bouwman P; Jonkers J
J Pathol; 2018 Sep; 246(1):41-53. PubMed ID: 29877575
[TBL] [Abstract][Full Text] [Related]
24. RANKL/RANK control Brca1 mutation- .
Sigl V; Owusu-Boaitey K; Joshi PA; Kavirayani A; Wirnsberger G; Novatchkova M; Kozieradzki I; Schramek D; Edokobi N; Hersl J; Sampson A; Odai-Afotey A; Lazaro C; Gonzalez-Suarez E; Pujana MA; Cimba F; Heyn H; Vidal E; Cruickshank J; Berman H; Sarao R; Ticevic M; Uribesalgo I; Tortola L; Rao S; Tan Y; Pfeiler G; Lee EY; Bago-Horvath Z; Kenner L; Popper H; Singer C; Khokha R; Jones LP; Penninger JM
Cell Res; 2016 Jul; 26(7):761-74. PubMed ID: 27241552
[TBL] [Abstract][Full Text] [Related]
25. Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones.
Lee EY
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):68-73. PubMed ID: 18197009
[TBL] [Abstract][Full Text] [Related]
26. Ulipristal acetate does not impact human normal breast tissue.
Communal L; Vilasco M; Hugon-Rodin J; Courtin A; Mourra N; Lahlou N; Dumont S; Chaouat M; Forgez P; Gompel A
Hum Reprod; 2012 Sep; 27(9):2785-98. PubMed ID: 22740493
[TBL] [Abstract][Full Text] [Related]
27. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
28. Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.
Esber N; Le Billan F; Resche-Rigon M; Loosfelt H; Lombès M; Chabbert-Buffet N
PLoS One; 2015; 10(10):e0140795. PubMed ID: 26474308
[TBL] [Abstract][Full Text] [Related]
29. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX
Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859
[TBL] [Abstract][Full Text] [Related]
30. Progesterone promotes immunomodulation and tumor development in the murine mammary gland.
Werner LR; Gibson KA; Goodman ML; Helm DE; Walter KR; Holloran SM; Trinca GM; Hastings RC; Yang HH; Hu Y; Wei J; Lei G; Yang XY; Madan R; Molinolo AA; Markiewicz MA; Chalise P; Axelrod ML; Balko JM; Hunter KW; Hartman ZC; Lange CA; Hagan CR
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33958486
[TBL] [Abstract][Full Text] [Related]
31. Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
Bartlett TE; Evans I; Jones A; Barrett JE; Haran S; Reisel D; Papaikonomou K; Jones L; Herzog C; Pashayan N; Simões BM; Clarke RB; Evans DG; Ghezelayagh TS; Ponandai-Srinivasan S; Boggavarapu NR; Lalitkumar PG; Howell SJ; Risques RA; Rådestad AF; Dubeau L; Gemzell-Danielsson K; Widschwendter M
Genome Med; 2022 Jun; 14(1):64. PubMed ID: 35701800
[TBL] [Abstract][Full Text] [Related]
32. Mammary gland development is mediated by both stromal and epithelial progesterone receptors.
Humphreys RC; Lydon J; O'Malley BW; Rosen JM
Mol Endocrinol; 1997 Jun; 11(6):801-11. PubMed ID: 9171243
[TBL] [Abstract][Full Text] [Related]
33. Ulipristal acetate resembles mifepristone in modulating human fallopian tube function.
Li HW; Liao SB; Yeung WS; Ng EH; O WS; Ho PC
Hum Reprod; 2014 Oct; 29(10):2156-62. PubMed ID: 25139173
[TBL] [Abstract][Full Text] [Related]
34. NF-κB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of
Sau A; Cabrita MA; Pratt MAC
Cancer Prev Res (Phila); 2018 Feb; 11(2):69-80. PubMed ID: 29101208
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.
Li M; Zhao D; Ma G; Zhang B; Fu X; Zhu Z; Fu L; Sun X; Dong JT
Biochem Biophys Res Commun; 2013 Jan; 430(1):358-63. PubMed ID: 23159610
[TBL] [Abstract][Full Text] [Related]
36. Targeting progesterone signaling prevents metastatic ovarian cancer.
Kim O; Park EY; Kwon SY; Shin S; Emerson RE; Shin YH; DeMayo FJ; Lydon JP; Coffey DM; Hawkins SM; Quilliam LA; Cheon DJ; Fernández FM; Nephew KP; Karpf AR; Widschwendter M; Sood AK; Bast RC; Godwin AK; Miller KD; Cho CH; Kim J
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):31993-32004. PubMed ID: 33262282
[TBL] [Abstract][Full Text] [Related]
37. Mifepristone mediates anti-proliferative effect on ovarian mesenchymal stem/stromal cells from female BRCA
Ponandai-Srinivasan S; Lalitkumar PG; Garcia L; Varghese SJ; Carlson JW; Gemzell-Danielsson K; Floter Radestad A
Acta Obstet Gynecol Scand; 2019 Feb; 98(2):250-261. PubMed ID: 30325501
[TBL] [Abstract][Full Text] [Related]
38. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
39. Ontogenic and nutritional regulation of steroid receptor and IGF-I transcript abundance in the prepubertal heifer mammary gland.
Meyer MJ; Rhoads RP; Capuco AV; Connor EE; Hummel A; Boisclair YR; Van Amburgh ME
J Endocrinol; 2007 Oct; 195(1):59-66. PubMed ID: 17911397
[TBL] [Abstract][Full Text] [Related]
40. Z-Endoxifen prevents aggressive mammary cancers in mice by inhibiting cell proliferation and creating a tumor suppressive microenvironment.
Lee O; Wang M; Hosseini O; Bosland MC; Muzzio M; Helenowski I; Khan SA
Biomed Pharmacother; 2023 Jun; 162():114607. PubMed ID: 37001185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
